The Duke Margolis Center for Health Policy, in collaboration with the FDA, is convening a virtual two-day workshop May 24-25 from 12pm ET – 4pm ET, titled “Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More.” This workshop will be of key relevance to a wide array of faculty, staff, and students working in basic, translational, and clinical sciences that support the development of therapeutics.

Register here: https://healthpolicy.duke.edu/events/translational-science-drug-development-surrogate-endpoints-biomarkers-and-more

For any questions about the workshop, please feel free to reach out to Erin Soule or Nancy Allen Lapointe.